LE WE PMID CA
Radiation therapy2623Strahlentherapie

2 deoxyglucose

Angiogenesis

Apoptosis

Auger electron

bFGF

Bone (Metastasis)

Bone (Neoplasia)

Bone (Traumatology)

Boron neutron capture therapy

Brachytherapy

Carbon ion radiotherapy

Caspase9

CNS (Metastasis)

CNS (Neoplasia Glioblastoma)

CNS (Neoplasia Glioma)

CNS (Neoplasia)

Cushing s disease

DNA (Repair and Toxicology)

Gene transfer

HIF1alpha und HIF1 (BASKET)

High LET irradiation

HZE particles

IETD ttCaspase9

Interleukin24 MDA7

JNK

Kidney (Toxicology)

LEHD ttCaspase9

Lung and bronchial system (Neoplasia)

Lymphoma (BASKET)

Microbeam

Neoplasia (PET)

Neoplasia (Tumor biology and immunology)

PEG feeding tube

Positron emission tomography (Method)

Prostate (Neoplasia)

Radiation damage and control

Radiation therapy

Radioimmunotherapy and radioligandtherapy

Radioprotector

Radiosensitizer

Razoxane

Sarcoma

SP600125 ttJNK1 ttJNK2 ttJNK3

Stem cell (Embryonal)

Stem cell (Neoplasia)

VEGF

zVAD ttCaspases

2005  
1
Radiotherapy basics for family physicians. Potent tool for symptom relief.
[16353832] Can Fam Physician 51(-): 1496-501 (2005)
1998  
2
Radiotherapy with heavy ions: radiobiology, clinical indications and experience at GSI, Darmstadt.
[9620245] Tumori 84(2): 200-4 (1998)
1998  
3
Hadrontherapy in the world and the programmes of the TERA Foundation.
[9620244] Tumori 84(2): 188-99 (1998)
2005  
4
New techniques in irradiation: clinical implications of perioperative high-dose rate brachytherapy.
[15958480] Ann Oncol 16 Suppl 2(-): ii73-8 (2005)
2005  
5
1994  
6
2007  
7
A review of hypofractionated palliative radiotherapy.
[17330854] Cancer 109(8): 1462-70 (2007)
2007  
8
Current status of radiotherapy with proton and light ion beams.
[17326046] Cancer 109(7): 1227-38 (2007)
2005  
9
The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.
[16080176] Cancer 104(6): 1129-37 (2005)
2003  
10
Molecular targets for radiation therapy: bringing preclinical data into clinical trials.
[14506136] Clin Cancer Res 9(10 Pt 1): 3518-20 (2003)
2003  
11
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
[12796357] Clin Cancer Res 9(6): 1957-71 (2003)
2006  
12
Quarks, leptons, fermions, and bosons--the subatomic world of radiation therapy.
[16401714] Oncologist 11(1): 62-4 (2006)
1999  
13
Induction of cell death by radiotherapy.
[10732785] Endocr Relat Cancer 6(1): 41-4 (1999)
2005  
14
Radiosurgery--LINAC or gamma knife: 20 years of controversy revisited.
[16190483] Isr Med Assoc J 7(9): 583-8 (2005)
2005  
15
Current status of tumor radiogenic therapy.
[15918182] World J Gastroenterol 11(20): 3014-9 (2005)
2006  
16
HCPBM [Heavy Charged Particles in Biology & Medicine] and ENLIGHT [European Network for Light Ions] meetings, Oropa (Italy), June 2005.
[16585718] Br J Radiol 79(940): 278-84 (2006)
2006  
17
2006  
18
The case for particle therapy.
[16421401] Br J Radiol 79(937): 24-31 (2006)
2004  
19
Clinical use of intensity-modulated radiotherapy: part II.
[15020357] Br J Radiol 77(915): 177-82 (2004)
2004  
20
Clinical use of intensity-modulated radiotherapy: part I.
[15010378] Br J Radiol 77(914): 88-96 (2004)
2003  
21
Intensity-modulated radiotherapy (IMRT): the most important advance in radiotherapy since the linear accelerator?
[14512325] Br J Radiol 76(910): 673 (2003)
2000  
22
2000  
23
Intensity modulated radiation therapy: a clinical review.
[10884741] Br J Radiol 73(869): 459-69 (2000)
1977  
24
1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
[409189] AJR Am J Roentgenol 129(3): 383-93 (1977)
1998  
25
Radionuclide cancer therapy.
[9637275] Ann Nucl Med 12(2): 61-70 (1998)
2009  
26
Has the time come for doing away with Cobalt-60 teletherapy for cancer treatments.
[20098538] J Med Phys 34(2): 63-5 (2009)
2006  
27
Radioimmunotherapy of solid tumors: the promise of pretargeting strategies using bispecific antibodies and radiolabeled haptens.
[16455623] J Nucl Med 47(2): 196-9 (2006)
2005  
28
The promise of targeted {alpha}-particle therapy.
[15653670] J Nucl Med 46 Suppl 1(-): 199S-204S (2005)
2005  
29
Induction of apoptosis with hybrids of Arg-Gly-Asp molecules and peptides and antimitotic effects of hybrids of cytostatic drugs and peptides.
[15653669] J Nucl Med 46 Suppl 1(-): 191S-8S (2005)
2005  
30
2004  
31
Implementing biologic target volumes in radiation treatment planning for non-small cell lung cancer.
[14736840] J Nucl Med 45 Suppl 1(-): 96S-101S (2004)
2000  
32
Emerging roles for radiometabolic therapy of tumors based on auger electron emission.
[10994732] J Nucl Med 41(9): 1519-21 (2000)
2003  
33
Beta irradiation: new uses for an old treatment: a review.
[12640408] Eye (Lond) 17(2): 207-15 (2003)
2002  
34
Synergistic cell-killing effect of a combination of hyperthermia and heavy ion beam irradiation: in expectation of a breakthrough in the treatment of refractory cancers (review).
[11744989] Int J Mol Med 9(1): 11-8 (2002)
2007  
35
Laser-driven proton oncology--a unique new cancer therapy?
[17768168] Br J Radiol 80(959): 855-8 (2007)
2004  
36
Is tomotherapy the future of IMRT?
[15107318] Br J Radiol 77(916): 285-95 (2004)
2003  
37
IMRT: delivery techniques and quality assurance.
[14623777] Br J Radiol 76(911): 766-76 (2003)
2003  
38
The physical basis of IMRT and inverse planning.
[14512327] Br J Radiol 76(910): 678-89 (2003)
2000  
39
Radiotherapy for benign diseases.
[10884722] Br J Radiol 73(866): 121-2 (2000)
1998  
40
The clinical radiobiology of brachytherapy.
[9691890] Br J Radiol 71(845): 465-83 (1998)
2010  
41
Tomotherapy for neurofibromatosis Type 2: case report and review of the literature.
[20335436] Br J Radiol 83(988): e74-8 (2010)
2009  
42
The role of autophagy in sensitizing malignant glioma cells to radiation therapy.
[19430698] Acta Biochim Biophys Sin (Shanghai) 41(5): 341-51 (2009)
2011  
43
Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance.
[21984970] Am J Cancer Res 1(4): 521-30 (2011)
2007  
44
Radiosensitization of prostate cancer by priming the wild-type p53-dependent cellular senescence pathway.
[18059157] Cancer Biol Ther 6(8): 1165-70 (2007)
2007  
45
Radiation to control transgene expression in tumors.
[17611403] Cancer Biol Ther 6(7): 1005-12 (2007)
2009  
46
Modulating the tumor microenvironment to increase radiation responsiveness.
[19823031] Cancer Biol Ther 8(21): 1994-2001 (2009)
2009  
47
Identification and management of persistently active brachytherapy seed implants.
[19843718] AJR Am J Roentgenol 193(5): W403-6 (2009)
2009  
48
Radiation risk from pediatric cardiac catheterization: friendly fire on children with congenital heart disease.
[19858410] Circulation 120(19): 1847-9 (2009)
2010  
49
Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.
[20811605] J Biomed Biotechnol 2010(-): - (2010)
2010  
50
Immunological aspects of local radiotherapy: clinical relevance.
[20193637] Discov Med 9(45): 119-24 (2010)
2002  
51
Impact of tumor hypoxia and anemia on radiation therapy outcomes.
[12490737] Oncologist 7(6): 492-508 (2002)
2010  
52
Radioprotectors and mitigators of radiation-induced normal tissue injury.
[20413641] Oncologist 15(4): 360-71 (2010)
2010  
53
Recent advances in combined modality therapy.
[20413642] Oncologist 15(4): 372-81 (2010)
2010  
54
Overcoming radiation resistance in inflammatory breast cancer.
[20503417] Cancer 116(11 Suppl): 2840-5 (2010)
2005  
55
Intensity-modulated radiation therapy: emerging cancer treatment technology.
[15856036] Br J Cancer 92(10): 1819-24 (2005)
2007  
56
Boron neutron capture therapy in cancer: past, present and future.
[17891250] Arq Bras Endocrinol Metabol 51(5): 852-6 (2007)
2007  
57
Radiotherapy and radiosurgery for Cushing's disease.
[18209876] Arq Bras Endocrinol Metabol 51(8): 1373-80 (2007)
2011  
58
Image-guided radiotherapy: a new dimension in radiation oncology.
[21603562] Dtsch Arztebl Int 108(16): 274-80 (2011)
2011  
59
Magnetic resonance imaging in assessment of treatment response of gamma knife for brain tumors.
[21740852] Chin Med J (Engl) 124(12): 1906-10 (2011)
2011  
60
Irradiation of human tumor tissue cultures: optimizing ion radiation therapy.
[21463137] Future Oncol 7(4): 489-91 (2011)
2010  
61
Are cancer stem cells radioresistant?
[21062156] Future Oncol 6(10): 1563-76 (2010)
2008  
62
Predicting response to clinical radiotherapy: past, present, and future directions.
[18376382] Cancer Control 15(2): 151-6 (2008)
2008  
63
The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy.
[18376381] Cancer Control 15(2): 140-50 (2008)
2008  
64
Functional lung imaging in thoracic cancer radiotherapy.
[18376378] Cancer Control 15(2): 112-9 (2008)
2008  
65
Stereotactic body radiation therapy: transcending the conventional to improve outcomes.
[18376377] Cancer Control 15(2): 104-11 (2008)
2004  
66
Radioimmunotherapy with alpha-particle emitting radionuclides.
[15640792] Q J Nucl Med Mol Imaging 48(4): 289-96 (2004)
2010  
67
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention.
[20554737] J Nucl Med 51(7): 1049-58 (2010)
2010  
68
Novel radiotherapy schedules aid recovery of normal tissues after treatment.
[20361066] J Gastrointestin Liver Dis 19(1): 7-8 (2010)
2008  
69
MDA-7/IL-24 plus radiation enhance survival in animals with intracranial primary human GBM tumors.
[18376144] Cancer Biol Ther 7(6): 917-33 (2008)
2004  
70
Potential use of MDA-7 as a biological adjuvant for radiation therapy.
[15326389] Cancer Biol Ther 3(8): 752-4 (2004)
2004  
71
MDA-7 regulates cell growth and radiosensitivity in vitro of primary (non-established) human glioma cells.
[15197348] Cancer Biol Ther 3(8): 739-51 (2004)
2003  
72
mda-7 (IL-24) Inhibits growth and enhances radiosensitivity of glioma cells in vitro via JNK signaling.
[14508103] Cancer Biol Ther 2(4): 347-53 (2003)
2010  
73
Embryonic stem cell (ESC)-mediated transgene delivery induces growth suppression, apoptosis and radiosensitization, and overcomes temozolomide resistance in malignant gliomas.
[20523363] Cancer Gene Ther 17(9): 664-74 (2010)
2006  
74
Ionizing radiation enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human ovarian cancer.
[16646087] J Cell Physiol 208(2): 298-306 (2006)
2009  
75
Induction of cytokine gene expression in human thyroid epithelial cells irradiated with HZE particles (iron ions).
[19772464] Radiat Res 172(4): 437-43 (2009)
2004  
76
Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
[15194048] Mol Ther 9(6): 818-28 (2004)
2004  
77
Adenoviral-mediated mda-7 expression suppresses DNA repair capacity and radiosensitizes non-small-cell lung cancer cells.
[15273727] Oncogene 23(42): 7125-31 (2004)
2003  
78
Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner.
[12606943] Oncogene 22(8): 1164-80 (2003)
2008  
79
NF-kappa B-mediated adaptive resistance to ionizing radiation.
[17967430] Free Radic Biol Med 44(1): 1-13 (2008)
2010  
80
Targeting inflammatory pathways for tumor radiosensitization.
[20599771] Biochem Pharmacol 80(12): 1904-14 (2010)
2010  
81
Monte Carlo and experimental dosimetric study of the mHDR-v2 brachytherapy source.
[21358074] J Cancer Res Ther 6(4): 421-6 (2010)
2010  
82
Shielding in whole brain irradiation in the multileaf collimator era: dosimetric evaluation of coverage using SFOP guidelines against in-house guidelines.
[20622361] J Cancer Res Ther 6(2): 152-8 (2010)
2009  
83
Protection of normal cells and tissues during radio- and chemosensitization of tumors by 2-deoxy-D-glucose.
[20009291] J Cancer Res Ther 5 Suppl 1(-): S32-5 (2009)
2009  
84
Different ways to improve the clinical effectiveness of radioimmunotherapy in solid tumors.
[20009292] J Cancer Res Ther 5 Suppl 1(-): S36-40 (2009)
2009  
85
Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro.
[20009290] J Cancer Res Ther 5 Suppl 1(-): S27-31 (2009)
2009  
86
Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects.
[20009289] J Cancer Res Ther 5 Suppl 1(-): S21-6 (2009)
2009  
87
Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors.
[20009287] J Cancer Res Ther 5 Suppl 1(-): S16-20 (2009)
2011  
88
Prophylactic feeding tubes for patients with locally advanced head-and-neck cancer undergoing combined chemotherapy and radiotherapy-systematic review and recommendations for clinical practice.
[21874110] Curr Oncol 18(4): e191-201 (2011)
2010  
89
PET/CT-guided radiation therapy planning: from present to the future.
[20448373] Indian J Cancer 47(2): 126-33 (2010)
2009  
90
Radiation-induced bystander signalling in cancer therapy.
[19377507] Nat Rev Cancer 9(5): 351-60 (2009)
2003  
91
Development of investigational radiation modifiers.
[12734315] J Natl Cancer Inst 95(9): 646-51 (2003)
2008  
92
Clinically relevant standards for intensity-modulated radiation therapy dose prescription.
[18314470] J Natl Cancer Inst 100(5): 288-90 (2008)
2011  
93
Proton therapy in clinical practice.
[21527064] Chin J Cancer 30(5): 315-26 (2011)
2011  
94
Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties.
[21512653] World J Radiol 3(3): 66-9 (2011)
2010  
95
Proton therapy dosimetry using positron emission tomography.
[21160579] World J Radiol 2(4): 135-42 (2010)
2011  
96
Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.
[21484384] Eur J Nucl Med Mol Imaging 38 Suppl 1(-): S41-7 (2011)
2011  
97
90Y/177Lu-DOTATATE therapy: survival of the fittest?
[21755369] Eur J Nucl Med Mol Imaging 38(10): 1785-7 (2011)
2010  
98
The options for the future production of the medical isotope 99Mo.
[20544192] Eur J Nucl Med Mol Imaging 37(10): 1817-20 (2010)
2006  
99
The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.
[17040092] Sarcoma 2006(1): 87367 (2006)
2004  
100
Overview of samarium sm 153 lexidronam in the treatment of painful metastatic bone disease.
[16985930] Rev Urol 6 Suppl 10(-): S3-S12 (2004)
2011  
101
Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma.
[21651775] Radiat Oncol 6(-): 63 (2011)
2010  
102
Transperineal prostate brachytherapy, using I-125 seed with or without adjuvant androgen deprivation, in patients with intermediate-risk prostate cancer: study protocol for a phase III, multicenter, randomized, controlled trial.
[20964826] BMC Cancer 10(-): 572 (2010)
2007  
103
Radiotherapeutic alternatives for previously irradiated recurrent gliomas.
[17760992] BMC Cancer 7(-): 167 (2007)
2010  
104
Extracorporeal irradiated tumor bone: A reconstruction option in diaphyseal Ewing's sarcomas.
[20924479] Indian J Orthop 44(4): 390-6 (2010)
2010  
105
Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.
[19959028] Semin Radiat Oncol 20(1): 21-9 (2010)
2009  
106
New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells.
[19835868] Eur J Pharmacol 625(1-3): 151-5 (2009)
2008  
107
Helical tomotherapy: a fascinating technological concept that has matured into clinical reality.
[19044319] Technol Cancer Res Treat 7(6): 415-6 (2008)
2010  
108
Radiation therapy: state of the art and the future.
[20299738] J Med Invest 57(1-2): 1-11 (2010)
2010  
109
Three endpoints of in vivo tumour radiobiology and their statistical estimation.
[20148701] Int J Radiat Biol 86(2): 164-73 (2010)
2010  
110
Imaging for assessment of radiation-induced normal tissue effects.
[20171509] Int J Radiat Oncol Biol Phys 76(3 Suppl): S140-4 (2010)
2010  
111
Hybrid computational phantoms for medical dose reconstruction.
[20039051] Radiat Environ Biophys 49(2): 155-68 (2010)
2010  
112
The role of whole brain radiation therapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.
[19960231] J Neurooncol 96(1): 17-32 (2010)
2011  
113
How can we overcome tumor hypoxia in radiation therapy?
[21952313] J Radiat Res (Tokyo) 52(5): 545-56 (2011)
2010  
114
Current advancement in radiation therapy for uterine cervical cancer.
[20173313] J Radiat Res (Tokyo) 51(1): 1-8 (2010)
2010  
115
Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS).
[20508375] J Radiat Res (Tokyo) 51(4): 355-64 (2010)
2010  
116
Recent innovations in carbon-ion radiotherapy.
[20679740] J Radiat Res (Tokyo) 51(4): 385-92 (2010)
2009  
117
Microbeam studies of the bystander response.
[19346680] J Radiat Res (Tokyo) 50 Suppl A(-): A1-6 (2009)
2009  
118
High LET heavy ion radiation induces p53-independent apoptosis.
[18957831] J Radiat Res (Tokyo) 50(1): 37-42 (2009)
2010  
119
Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.
[20135685] Stem Cells 28(4): 639-48 (2010)
2009  
120
Radiation responses of cancer stem cells.
[19623582] J Cell Biochem 108(2): 339-42 (2009)
2009  
121
Hypoxia and radiation therapy: past history, ongoing research, and future promise.
[19519402] Curr Mol Med 9(4): 442-58 (2009)
2010  
122
Patient positioning in the proton radiotherapy era.
[20465816] J Exp Clin Cancer Res 29(-): 47 (2010)
2010  
123
Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy.
[21076193] Phys Med Biol 55(23): 7009-23 (2010)
2010  
124
2010  
125
The tumor-immune microenvironment and response to radiation therapy.
[21161342] J Mammary Gland Biol Neoplasia 15(4): 411-21 (2010)
2010  
126
CyberKnife stereotactic ablative radiotherapy for lung tumors.
[21070081] Technol Cancer Res Treat 9(6): 589-96 (2010)
2010  
127
CyberKnife(R) robotic stereotactic radiosurgery and stereotactic body radiation therapy.
[21070075] Technol Cancer Res Treat 9(6): 539-40 (2010)
PMC   
128
Improving radiotherapy planning, delivery accuracy, and normal tissue sparing using cutting edge technologies.
[24688775] J Thorac Dis 6(4):303-18 (2014)
PMC   
129
Exploiting sensitization windows of opportunity in hyper and hypo-fractionated radiation therapy.
[24688774] J Thorac Dis 6(4):287-302 (2014)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Supportive Maßnahmen in der Radioonkologie


  • Strahlentherapie

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia